Nakanishi Tomohiro, Oyama Kotaro, Tanaka Hiroyuki, Kobirumaki-Shimozawa Fuyu, Ishii Shuya, Terui Takako, Ishiwata Shin'ichi, Fukuda Norio
Department of Cell Physiology, The Jikei University School of Medicine, Tokyo, Japan.
Department of Anesthesiology, The Jikei University School of Medicine, Tokyo, Japan.
Front Physiol. 2022 Aug 23;13:947206. doi: 10.3389/fphys.2022.947206. eCollection 2022.
Omecamtiv mecarbil (OM) is a novel inotropic agent for heart failure with systolic dysfunction. OM prolongs the actomyosin attachment duration, which enhances thin filament cooperative activation and accordingly promotes the binding of neighboring myosin to actin. In the present study, we investigated the effects of OM on the steady-state contractile properties in skinned porcine left ventricular (PLV) and atrial (PLA) muscles. OM increased Ca sensitivity in a concentration-dependent manner in PLV, by left shifting the mid-point (pCa) of the force-pCa curve (ΔpCa) by ∼0.16 and ∼0.33 pCa units at 0.5 and 1.0 μM, respectively. The Ca-sensitizing effect was likewise observed in PLA, but less pronounced with ΔpCa values of ∼0.08 and ∼0.22 pCa units at 0.5 and 1.0 μM, respectively. The Ca-sensitizing effect of OM (1.0 μM) was attenuated under enhanced thin filament cooperative activation in both PLV and PLA; this attenuation occurred directly via treatment with fast skeletal troponin (ΔpCa: ∼0.16 and ∼0.10 pCa units in PLV and PLA, respectively) and indirectly by increasing the number of strongly bound cross-bridges in the presence of 3 mM MgADP (ΔpCa: ∼0.21 and ∼0.08 pCa units in PLV and PLA, respectively). It is likely that this attenuation of the Ca-sensitizing effect of OM is due to a decrease in the number of "recruitable" cross-bridges that can potentially produce active force. When cross-bridge detachment was accelerated in the presence of 20 mM inorganic phosphate, the Ca-sensitizing effect of OM (1.0 μM) was markedly decreased in both types of preparations (ΔpCa: ∼0.09 and ∼0.03 pCa units in PLV and PLA, respectively). The present findings suggest that the positive inotropy of OM is more markedly exerted in the ventricle than in the atrium, which results from the strongly bound cross-bridge-dependent allosteric activation of thin filaments.
奥米卡替明(OM)是一种用于治疗收缩功能障碍性心力衰竭的新型正性肌力药物。OM延长了肌动球蛋白附着持续时间,增强了细肌丝协同激活,从而促进相邻肌球蛋白与肌动蛋白的结合。在本研究中,我们研究了OM对去表皮猪左心室(PLV)和心房(PLA)肌肉稳态收缩特性的影响。OM在PLV中以浓度依赖性方式增加钙敏感性,在0.5 μM和1.0 μM时,分别使力-钙曲线的中点(pCa)左移约0.16和0.33个pCa单位(ΔpCa)。在PLA中同样观察到钙增敏作用,但在0.5 μM和1.0 μM时,ΔpCa值分别约为0.08和0.22个pCa单位,作用较弱。在PLV和PLA中,增强细肌丝协同激活时,OM(1.0 μM)的钙增敏作用减弱;这种减弱直接通过快速骨骼肌肌钙蛋白处理发生(PLV和PLA中ΔpCa分别约为0.16和0.10个pCa单位),间接通过在3 mM MgADP存在下增加强结合横桥数量发生(PLV和PLA中ΔpCa分别约为0.21和0.08个pCa单位)。OM钙增敏作用的这种减弱可能是由于潜在产生主动力的“可募集”横桥数量减少。当在20 mM无机磷酸盐存在下加速横桥解离时,两种制剂中OM(1.0 μM)的钙增敏作用均显著降低(PLV和PLA中ΔpCa分别约为0.09和0.03个pCa单位)。目前的研究结果表明,OM的正性肌力作用在心室中比在心房中更明显地发挥,这是由细肌丝的强结合横桥依赖性变构激活导致的。